These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 23016589)
1. lGnRH-III -- a promising candidate for anticancer drug development. Manea M; Mező G Protein Pept Lett; 2013 Apr; 20(4):439-49. PubMed ID: 23016589 [TBL] [Abstract][Full Text] [Related]
2. Structure, enzymatic stability and antitumor activity of sea lamprey GnRH-III and its dimer derivatives. Mezo G; Czajlik A; Manea M; Jakab A; Farkas V; Majer Z; Vass E; Bodor A; Kapuvári B; Boldizsár M; Vincze B; Csuka O; Kovács M; Przybylski M; Perczel A; Hudecz F Peptides; 2007 Apr; 28(4):806-20. PubMed ID: 17254668 [TBL] [Abstract][Full Text] [Related]
4. Is lGnRH-III the most potent GnRH analog containing only natural amino acids that specifically inhibits the growth of human breast cancer cells? Herédi-Szabó K; Murphy RF; Lovas S J Pept Sci; 2006 Nov; 12(11):714-20. PubMed ID: 16967433 [TBL] [Abstract][Full Text] [Related]
5. GnRH-III based multifunctional drug delivery systems containing daunorubicin and methotrexate. Leurs U; Lajkó E; Mező G; Orbán E; Öhlschläger P; Marquardt A; Kőhidai L; Manea M Eur J Med Chem; 2012 Jun; 52():173-83. PubMed ID: 22480495 [TBL] [Abstract][Full Text] [Related]
6. Seasonal changes of brain GnRH-I, -II, and -III during the final reproductive period in adult male and female sea lamprey. Sower SA; Balz E; Aquilina-Beck A; Kavanaugh SI Gen Comp Endocrinol; 2011 Jan; 170(2):276-82. PubMed ID: 20709062 [TBL] [Abstract][Full Text] [Related]
7. Importance of the central region of lamprey gonadotropin-releasing hormone III in the inhibition of breast cancer cell growth. Herédi-Szabó K; Lubke J; Toth G; Murphy RF; Lovas S Peptides; 2005 Mar; 26(3):419-22. PubMed ID: 15652648 [TBL] [Abstract][Full Text] [Related]
8. Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptor. Montagnani Marelli M; Manea M; Moretti RM; Marzagalli M; Limonta P Int J Oncol; 2015 Jan; 46(1):243-53. PubMed ID: 25351635 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity study on the LH- and FSH-releasing and anticancer effects of gonadotropin-releasing hormone (GnRH)-III analogs. Kovács M; Vincze B; Horváth JE; Seprodi J Peptides; 2007 Apr; 28(4):821-9. PubMed ID: 17289216 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, enzymatic stability and in vitro cytostatic effect of Daunorubicin-GnRH-III derivative dimers. Schreier VN; Mező G; Orbán E; Dürr C; Marquardt A; Manea M Bioorg Med Chem Lett; 2013 Apr; 23(7):2145-50. PubMed ID: 23434423 [TBL] [Abstract][Full Text] [Related]
11. Primary structure and biological activity of a third gonadotropin-releasing hormone from lamprey brain. Sower SA; Chiang YC; Lovas S; Conlon JM Endocrinology; 1993 Mar; 132(3):1125-31. PubMed ID: 8440174 [TBL] [Abstract][Full Text] [Related]
12. Co-localization of three gonadotropin-releasing hormone transcripts in larval, parasitic, and adult sea lamprey brains. Van Gulick ER; Marquis TJ; Sower SA Gen Comp Endocrinol; 2018 Aug; 264():84-93. PubMed ID: 28782533 [TBL] [Abstract][Full Text] [Related]
13. Influence of synthetic lamprey GnRH-III on gonadotropin release and steroid hormone levels in gilts. Brüssow KP; Schneider F; Tuchscherer A; Kanitz W Theriogenology; 2010 Dec; 74(9):1570-8. PubMed ID: 20708243 [TBL] [Abstract][Full Text] [Related]
14. Patterns of proopiomelanotropin and proopiocortin gene expression and of immunohistochemistry for gonadotropin-releasing hormones (lGnRH-I and III) during the life cycle of a nonparasitic lamprey: relationship to this adult life history type. Youson JH; Heinig JA; Khanam SF; Sower SA; Kawauchi H; Keeley FW Gen Comp Endocrinol; 2006 Aug; 148(1):54-71. PubMed ID: 16364323 [TBL] [Abstract][Full Text] [Related]
15. 15alpha-hydroxytestosterone induction by GnRH I and GnRH III in Atlantic and Great Lakes sea lamprey (Petromyzon marinus L.). Young BA; Bryan MB; Sower SA; Scott AP; Li W Gen Comp Endocrinol; 2004 Apr; 136(2):276-81. PubMed ID: 15028532 [TBL] [Abstract][Full Text] [Related]
16. Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates. Hegedüs R; Manea M; Orbán E; Szabó I; Kiss E; Sipos E; Halmos G; Mező G Eur J Med Chem; 2012 Oct; 56():155-65. PubMed ID: 22967796 [TBL] [Abstract][Full Text] [Related]
17. New derivatives of GnRH as potential anticancer therapeutic agents. Mezo G; Manea M; Szabí I; Vincze B; Kovács M Curr Med Chem; 2008; 15(23):2366-79. PubMed ID: 18855666 [TBL] [Abstract][Full Text] [Related]
18. Investigation on chemotactic drug targeting (chemotaxis and adhesion) inducer effect of GnRH-III derivatives in Tetrahymena and human leukemia cell line. Lajkó E; Szabó I; Andódy K; Pungor A; Mező G; Kőhidai L J Pept Sci; 2013 Jan; 19(1):46-58. PubMed ID: 23208929 [TBL] [Abstract][Full Text] [Related]
19. Evidence that lamprey GnRH-III does not release FSH selectively in cattle. Amstalden M; Zieba DA; Garcia MR; Stanko RL; Welsh TH; Hansel WH; Williams GL Reproduction; 2004 Jan; 127(1):35-43. PubMed ID: 15056768 [TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine and behavioral responses to weak electric fields in adult sea lampreys (Petromyzon marinus). Chung-Davidson YW; Bryan MB; Teeter J; Bedore CN; Li W Horm Behav; 2008 Jun; 54(1):34-40. PubMed ID: 18329031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]